Alessandra Fusco, Sara Colarusso, Marco Piscopo, Maria Rosaria Improta, & Marco Corigliano. (2017). Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience. Heart Research, 4(3), 46–56. https://doi.org/10.17140/HROJ-4-141